Webinar

Unravels- The Relevance of Low Dose Modern SU in New Age- A Discussion

11th November, 2022
07:30 AM
Unravels- The Relevance of Low Dose Modern SU in New Age- A Discussion

Overview

Modern SUs can be considered a panacea in DM care with their beneficial extra-pancreatic, pleiotropic, and cardiovascular effects. Sulfonylureas also exhibit certain endocrine and metabolic effects, which could be considered beneficial in the management of DM. Additionally, Safe glycemic control with SUs could be achieved. But, what are the factors that affect the drug and dosage selection? Is it beneficial in comparison to the other drugs in the market with a similar profile? Why sulfonylureas? Let's understand these facts in this session of a webcast titled," unravel the relevance of low dose modern SU in new age".

  Moderators

Dr. Arundhati Dasgupta

Dr. Arundhati Dasgupta

Director and Consultant Endocrinologist at Rudraksh Superspeciality Care, Siliguri, West Bengal

Dr. Suneet Kumar Verma

Dr. Suneet Kumar Verma

MD, Department of Internal Medicine at Sparsh Clinic, Panchkula

Dr. Raka Sheohare

Dr. Raka Sheohare

Director lifeline Madhumeet Diabetes Hospital, Raipur, India

Dr. Kartik Balachandran

Dr. Kartik Balachandran

MBBS, MD - (General Medicine) DM - ( Endocrinology) JIPMER Chennai

  Speaker

Dr. Sanjay Kalra

Dr. Sanjay Kalra

DM (AIIMS) President-elect, SAFES Bharti Hospital, Karnal, India